| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.8M | -9.3% |
| R&D Expense | $3.8M | -15.6% |
| SG&A Expense | $26.8M | +51.4% |
| Operating Income | -$32.2M | -57.3% |
| Income Tax | -$1K | -162.5% |
| Net Income | -$30.8M | -77.2% |
| EPS (Basic) | -$75.65 | -181.0% |
| EPS (Diluted) | -$75.65 | -181.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.5M | +1371.7% |
| Accounts Receivable | $1.1M | -49.0% |
| Inventory | $801K | -82.6% |
| Current Assets | $11.0M | +19.0% |
| Total Assets | $17.4M | +3.5% |
| Current Liabilities | $9.8M | -13.8% |
| Long-term Debt | $1.7M | -68.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.6M | -5.7% |
| Capital Expenditures | $57K | +25.8% |
| Investing Cash Flow | $518K | +1240.8% |
| Financing Cash Flow | $21.2M | +46.6% |
| Free Cash Flow | -$16.7M | -5.7% |
| $14.9M |
| -17.8% |
| Stockholders' Equity | -$1.7M | -32.7% |